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1. INTRODUCTION 
Policy makers have focussed considerable efforts on improving healthcare quality and its 
efficient provision at the hospital-level (Scott, 2009). One effective intervention for triggering 
change is the introduction of centralised treatment centres, where the bundling of clinical 
expertise translates into enhanced service delivery, characterised by efficiently applied 
processes and improved clinical outcomes. Successful centralisations are documented in 
cancer care (Lemmens et al., 2011; Gooiker et al., 2011), with specialist units leading to 
reduced 30-day mortality and overall costs, mainly because of decreases in length of stay 
(Lemmens et al., 2011; Gooiker et al., 2011). The primary theory underlying centralisation is 
the physician/unit-volume effect (Schmidt et al., 2010; Freeman et al., 2012; Svendsen, 
Ehlers, Ingeman and Johnsen, 2012; Halm, Lee and Chassin, 2000), whereby clinical staff 
enhance their ability to perform specialist tasks through continuous repetition, which leads to 
better patient outcomes. While the effectiveness of centralisation for surgical interventions is 
well documented, little is known about its effectiveness in acute settings, such as stroke 
(Kanhere, Kanhere, Cameron and Maddern, 2012).  
Stroke is the leading cause for mortality and disability in developed countries (Mathers, 
Boerma and Ma Fat, 2009). The high incidence combined with potentially life changing 
clinical effects imposes a significant burden on society and health care providers (Smith et 
al., 2012; Di Carlo, 2009; Fattore et al., 2012; Persson, Ferraz-Nunes and Karlberg, 2012). 
The direct treatment costs in England total £3-4.4 billion (Houses of Parliament, 2014) and  
outcomes and long-term recovery from a stroke is highly variable (Reistetter et al., 2014). 
Apart from clinical severity, it is highly influenced by the management of stroke pathways 
and provision of high quality of care (Clarke and Forster, 2015). This includes the capacity to 
respond to early symptoms, for example providing immediate access to specialist 
thrombolytic drugs for eligible patients (Lecouturier et al., 2010).  
Since 2010, all acute stroke patients in London are expected to receive treatment within 
one of eight Hyper Acute Stroke Units (HASUs) that cover the first 72 hours of the acute 
stroke episode. Post-policy implementation, twenty-six hospitals were meant to cease the 
provision of acute stroke care, and centralising services intended to offer equal and accessible 
high quality procedures, bundling clinical expertise and to subsequently improve patient 
outcomes (Healthcare for London, 2008). Previous impact evaluations found positive 
associations between stroke care centralisation and improvements in processes and outcomes 
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(Liu, Rudd and Davie, 2011; Hunter et al., 2013; Fulop et al., 2013; Morris et al., 2014; 
Ramsay et al., 2015).     
        Despite clear structuring of stroke pathways in London, descriptive statistics of patient 
flow show that some London non-HASU Trusts continued treating stroke patients after the 
implementation of the centralisation policy. Approximately 15 per cent of all London stroke 
patients still received stroke care in non-HASUs in 2012, with the number of stroke 
admissions to non-HASUs decreasing gradually (see Figure 1). This appears contrary to the 
intention of the centralisation policy and has been disregarded by previous research. While 
estimations of an overall area-level treatment effect provide insights into changes across a 
pooled group of healthcare providers, findings disguise the heterogeneity in treatment effects 
within provider groups. This is of particular concern with regards to stroke care in London, 
because approximately 350 patients still receive care in non-HASU trusts every quarter.  
The innovative contribution of this study is to assess the impact of centralised stroke care 
in London on seven process and outcome indicators, separately for patients admitted to 
HASUs and for patients admitted to non-HASUs. We apply a difference- in-difference 
analysis with two treatment groups to all English stroke patients recorded in the Hospital 
Episode Statistics database (HES) from April 2006 to April 2014. This methodology provides 
a tool to investigate potentially systematic differences between patients receiving care in 
London trusts that can result from lower levels of clinical engagement or limited availability 
of equipment to provide stroke specific processes, which is disguised by a one treatment 
group methodology.  
2. BACKGROUND 
In 2010, the two largest metropolitan areas in England, London and Greater 
Manchester, performed a reorganisation of stroke care aimed at streamlining stroke services 
through service centralisation. Prior to the policy introduction, 30 London hospitals provided 
acute stroke services across the city, of which 26 were expected to terminate service 
provision following the introduction of the policy in April 2010. Eight trusts were converted 
into HASUs in London, with the objective of improving stroke processes and outcomes, as 
well as saving costs in the long run (Healthcare for London, 2008). The identification of 
trusts that should become HASUs followed a modelling exercise (Fulop et al., 2013), 
addressing not only population need and configuration requirements, but also an ambulance 
travelling time of maximum 30 minutes to the closest facility, given any possible stroke 
4 
 
patient location within the London catchment area. All HASUs are equipped with stroke-
specialised staff that provides 24/7 stroke care for patients, covering the first 72 hours of the 
acute stroke episode. Following 72 hours, stroke patients will either be directed to another 
stroke unit based on the locality of their residence, which in many cases is located in a non-
HASU trust, or will be discharged depending on their level of recovery.  
Several empirical studies investigated the effectiveness of centralised stroke care in 
England (Liu, Rudd and Davie, 2011; Hunter et al., 2013; Fulop et al., 2013; Morris et al., 
2014; Ramsay et al., 2015). Early effects showing increased thrombolysis rates (12 per cent), 
discharge to home rates (35 per cent), and reductions in 30-day mortality rates (6 per cent) 
were reported by Liu, Rudd and Davie (2011), and interpreted as a direct effect of 
centralisation. The method used in the study was a before and after comparison of crude rates 
that were not adjusted for patient case-mix and based on data from one HASU trust. Further 
methodological limitations relate to the isolation of policy effects from general improvements 
in stroke care and non-adjustment for pre-policy performance heterogeneity between trusts. 
In particular, some trusts that eventually transformed into HASUs already provided leading 
stroke services, e.g. thrombolysis treatments in the King’s College London trust, whereas 
other HASUs had to be newly built and subsequently showed low levels of pre-policy 
engagement in similar processes. As a result, the observed jump in thrombolysis rates and 
mortality could be more prominent in trusts that had lower baseline experiences.  
Hunter et al. (2013) conducted a before and after cost-effectiveness analysis of the 
stroke policy in London, with a particular focus on time trends in mortality and length of stay. 
The study used Cox Proportional hazards and Weibull survival analysis to evaluate changes 
in outcome and cost. According to the findings of the study, the reorganisation led to 
improved survival rates illustrated by Kaplan-Meier survival curves, fewer overall deaths, 
and a cost reduction per stroke patient of £811. A variety of datasets were used, capturing a 
sub-section of stroke patient in London. Data sources included the South London Stroke 
Register, which holds information on patients consented to the collection and storage of their 
information, and data from two hospitals based in North London. Similar to Liu et al. (2011), 
findings are therefore not representative of the treatment effect on the whole stroke 
population in London.  
Morris et al. (2014) provided the first impact evaluation on the centralisation 
approach implemented in London as well as Greater Manchester. Difference- in-difference 
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regression methods were used to compare trends in outcomes between London, Greater 
Manchester and the rest of England. The method accounted for time trends and was 
conducted at the hospital-level, using patient-level records from the HES database, and 
focussed on all urban-living stroke patients in England admitted to a hospital within the study 
period. The study compared area-wide changes in the whole of London to changes that 
occurred in the rest of England, and findings supported previously established improvements 
in outcomes, with significant decreases found for 30-day mortality rates (-1.3 per cent) and 
length of stay (-1.4 days). However, the study has limitations. The use of the classical 
difference- in-difference design averages provider performance in London and compares it to 
changes in the average performance within the rest of England. Morris et al. (2014) failed to 
address the differential impact on stroke patients in London, given that non-HASUs 
continued to provide acute stroke care. Even though the applied method allowed for estimates 
of the area-wide impact of the policy, it provided no insight into heterogeneity of 
implementation practice between providers.  In fact, deviation from guidelines by some 
providers could undermine efforts of quality improvements and subsequently dilute 
previously reported area-level treatment effects. 
Past research failed to consider the impact of possible policy deviation by non-
HASUs that continued to provide acute stroke treatment to stroke patients. To understand the 
potential impact of differential treatment received by stroke patient in London, an impact 
evaluation with two treatment groups is required. The methodological expansion in this study 
provides policy makers with a crucial insight into the performance variation between HAUSs 
and non-HASUs in London. 
3. DATA 
The study covers the period from April 2006 to April 2014, providing a panel of 16 
quarters before and 16 quarters after policy introduction in April 2010. The dataset contains 
patient information from a total of 224 English NHS trusts that have been treating stroke 
patients across the study period, including trusts that have merged or dissolved. To capture 
the potential impact of trust status change, we include a dummy variable for all London trusts 
that have merged with other trusts, hence absorbed another trust or dissolved.  
The eight HASUs are situated in hospitals belonging to eight NHS trusts. Over the 
observation period, mergers between HASU trusts and non-HASU trusts occurred, e.g. 
Whipps Cross University Hospital NHS Trust integrated into Barts Health and the London 
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NHS Trust, in 2012. We assume that after a trust merger, stroke patients were recorded under 
the new trust code, with the original trust disappearing from our analysis and hence coded as 
a missing value.  
We include all trusts that treated at least one patient per quarter. For some trusts and 
quarters we have missing values in our dataset, i.e. zero patients or missing values for some 
variables, which may be an indication of no stroke patients being treated or potentially poor 
coding practice that could impact our results. As a response we estimate an unbalanced panel. 
To avoid that the control group, rest of England, is driven by any changes that occurred 
through the area-wide stroke policy framework in Greater Manchester, eight trusts located in 
the Greater Manchester catchment area are excluded from this study. Additionally, we 
exclude the Epsom and St. Helier University Hospital NHS Trust, because of their location 
on the periphery of Greater London and subsequent limitation in assigning it to either the 
HASU, or control group. 
We use trust-level data, aggregated from the patient-level for all patients with a primary 
diagnosis of stroke, which was obtained from the HES database. Our final dataset was based 
on ‘super-spells’, i.e. linked continuous inpatient spells that hold information on patient 
demographics and treatment for the period between hospital admission and discharge. By 
definition, ‘super-spells’ are constructed from ‘spells’ that are separated by less than two 
days, which avoids double counting of patients in case of repatriation to a regular stroke unit 
in a non-HASU trust following an acute care ‘spell’ at a HASU trust. Stroke was defined 
based on ICD-10 (International Classification of Disease, 10th revision) codes – I61 
(intracerebral haemorrhage), I62 (other non-traumatic intracranial haemorrhage), I63 
(cerebral infarction), and I64 (stroke, not specified as haemorrhage or infarction). Patients 
with a primary diagnosis of subarachnoid haemorrhage are excluded, as this diagnosis was 
not part of the implemented hyper acute stroke care pathway in London.  
We focus on seven stroke specific processes and outcome measures, chosen to cover 
different critical points in the quality of stroke care along the medical pathway. The measures 
are based on findings of Palmer et al. (2013), which investigated the feasibility of using HES 
to derive measures for an evaluation of quality of stroke care at the trust-level. Assessed 
process and outcome measures are 24 hour brain scan rate; thrombolysis treatment rate; rate 
of patients suffering from hospital acquired aspiration pneumonia; 7-day and 30-day in-
hospital mortality rate; rate of patients discharged to their usual place of residence within 56 
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days of admission; and 30-day emergency readmission rates. Table I includes a definition of 
measures and Table II summary statistics.   
We control for average trust-specific covariates, patient age, Charlson index, gender 
ratio and hospital transfers rate. The transfer rate describes the proportion of patients coming 
from another A&E department before receiving acute stroke care. Time invariant regional 
variation of dependents is captured with dummy variables for seven separate English regions 
(North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of 
England, South East Central, South Central, and South West). 
Insert Table I Here 
Insert Table II Here 
4. ECONOMETRIC FRAMEWORK 
To evaluate the intervention, we use a difference- in-difference analysis (Ashenfelter and 
Card, 1985) - a widely used tool for estimating causal inference of health policies 
(Wooldridge, 2002; Propper, Whitnall, Sutton and Windmeijer, 2008). We estimate a 
difference- in-difference model that uses two-treatment groups, HASUs and London non-
HASUs (Marini, Miraldo, Jacobs and Goddard, 2008). We assume a constant difference 
between the two treatment groups and trusts in the rest of England given the absence of an 
intervention, as well as parallel trends in the process and outcome variables before the policy 
intervention. We tested for differences in pre-treatment trends of the treatment and 
comparison group. The main model of our difference- in-difference regression analysis is 
specified as:  𝑌𝑗𝑡 = 𝛽0 + 𝛽1 ∗ 𝑁𝑗 + 𝛽2 ∗ 𝐻𝑗 + 𝛽3 ∗ 𝑇𝑡 + 𝛽4 ∗ 𝑁𝑗𝑇𝑡 + 𝛽5 ∗ 𝐻𝑗𝑇𝑡 + 𝛽6 ∗ 𝑊𝑗𝑡 + 𝛽7 ∗ 𝑀𝑗 + 𝛽8 ∗ 𝑅𝑗 + 𝜀𝑗𝑡 + 𝜇𝑗    
(1) 
The dependent variable 𝑌𝑗𝑡 represents one of seven process or outcome indicators, in 
quarter t and trust j. For the first treatment group, 𝑁𝑗 takes the value of one if the trust is a 
non-HASU in London, and zero otherwise. For the second treatment group, 𝐻𝑗 takes the 
value of one if the trust is a HASU, and zero otherwise. Both variables are time invariant and 
capture systematic permanent differences between either the first or second treatment group 
and the control group, and the other treatment group. The coefficient estimate of 𝛽1 presents 
the differences in outcomes of non-HASU trusts in London compared to the rest of England 
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and HASU trusts, whereas 𝛽2 indicates the differences in outcome of HASUs compared to 
the rest of England and non-HASU trusts, for reasons unrelated to the reorganisation. Time 
dummy 𝑇𝑡 captures the time varying impacts on the dependent variable that affects both 
treatment and control groups, and takes the value of one for quarters after the reorganisation 
(17 to 32), and zero before (1 to 16). From quarter 17, the interaction term 𝑁𝑗𝑇𝑡and 𝐻𝑗𝑇𝑡 is 
one for non-HASUs and HASUs, respectively. The coefficient estimates for 𝛽4 and 𝛽5 
captures the impact of the reorganisation purged from the effects of other time varying and 
time invariant observed and unobserved impacts on the dependent variable. Time varying 
covariates, such as average age and gender rate, are represented in vector 𝑊𝑗𝑡. We further 
include a time invariant merger dummy 𝑀𝑗, and regional dummies 𝑅𝑗. The time invariant 
error 𝜇𝑗 captures unobserved random variations in processes and outcome across trusts that 
are stable over time; and the normally distributed error 𝜀𝑗𝑡 captures unobserved random 
shocks.  
We estimate alternative model specifications. The first replicates the analysis 
conducted by Morris et al. (2014) to compare changes in 30-day mortality rates and length of 
stay for all London trusts (HASUs and non-HASUs) to the control group, rest of England, 
using random effects. We acknowledge that previous findings may not be fully replicable due 
to several reasons. First, Morris et al. (2014) performed analysis at the hospital-level using 
patient-level data, whereas our analysis is restricted to aggregate data at the trust-level. 
Second, we estimate the treatment effect of centralisation in London compared to a control 
group comprising of all patients admitted to trusts within the rest of England, but excluding 
Greater Manchester, whereas the previous evaluation confined to patients living in urban 
areas. Finally, our study uses in-hospital mortality data derived from patient records, whereas 
Morris et al. (2014) used mortality data on all deaths including those occurred outside of 
hospital. In combination these differences can potentially lead to significant variations in 
replicating previous results. The difference- in-difference model is specified as: 
𝑌𝑗𝑡 = 𝛽0 + 𝛽1 ∗ 𝐿𝑗 + 𝛽2 ∗ 𝑇𝑡 + 𝛽3 ∗ 𝐿𝑗𝑇𝑡 + 𝛽4 ∗ 𝑊𝑗𝑡  + 𝜀𝑗𝑡 + 𝜇𝑗 (2) 
where the dummy variable 𝐿𝑗 takes the value of one if the trust is located in London, and 
zero otherwise. The time dummy 𝑇𝑡 is one after the reorganisation (April 2010 to March 
2012), and zero before (January 2008 to March 2010). The coefficient estimates of 𝐿𝑗𝑇𝑡 show 
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the policy effect on the dependent variable 𝑌𝑗𝑡, namely 30-day mortality and length of stay. 
Time varying covariates are represented in vector 𝑊𝑗𝑡 . 
We assess the validity of the control group with a specification that compares HASUs and 
non-HASUs in London to a control group containing trusts of seven English metropolitan 
areas (Birmingham, Bristol, Leeds, Liverpool, Sheffield, Southampton, and Newcastle). We 
assume systematic differences in the provision of health care services between rural and 
urban areas (Smith, Humphreys and Wilson, 2008) that could impact the time-to-treatment 
for patients and possibly lead to worse health outcomes (QualityWatch, 2014). We further 
perform Hausman model specification tests.  
5. RESULTS 
We identify 678 968 patients with a primary diagnosis of stroke in England, over the 
observation period. The number of quarterly recorded strokes increased throughout, and is 
12.4 per cent higher in quarter 32 compared to quarter 1. As shown in Figure 1, the 
proportion of London stroke patients admitted to trusts with HASU post-reorganisation and 
trusts with non-HASUs post-reorganisation is evenly split at approximately 50 per cent 
before the implementation of the centralisation policy. Immediately after the policy 
introduction, admission rates started to diverge and we observe a gradual increase in 
admissions to HASUs and a decrease in admissions to non-HASUs. Our data shows a 
levelling effect that occurred in quarter 23, beyond which admissions to HASUs account for 
about 85 per cent of all stroke admissions in London.  
Insert Figure 1 Here 
Appendix A illustrates plotted weighted time trends of dependent variables over the study 
period. We find that stroke processes and outcome measures improved across England. In 
London, weighted rates closely follow the time trend of HASUs, indicating that the 
performance in HASUs is the main driver for performance observed in the London area.  
Results from main model specification (1) 
Table III provides estimates of the difference- in-difference analysis using two 
treatment groups and comparing them to performance recorded in trusts based in the rest of 
England and the other treatment group, respectively. The number of observations used per 
analysis was 5147. For some outcome measures we reject the random effect specification 
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based on the Hausman test. For the estimations of a panel data model with fixed effects, all 
time invariant variables were omitted. We present results of the fixed effect specification for 
the models that failed the Hausman test in Appendix B. 
Insert Table III Here 
According to the coefficient estimate of 𝑇𝑡, we find an improvement in stroke care 
over time that is unrelated to the reorganisation. Across all English trusts, stroke processes 
were higher in the quarters after the reorganisation, with 22.9 per cent more patients scanned 
within 24 hours of hospital admission, and 4.3 per cent more patients receiving thrombolysis. 
7-day mortality and 30-day mortality was significantly lowered by 1.5 per cent and 3.7 per 
cent, respectively. The rates for aspiration pneumonia, discharge to usual place of residence 
and 30-day emergency readmission were significantly higher in quarter 16 to 32 compared to 
the pre-policy period. An additional 0.8 per cent of patients experienced aspiration 
pneumonia, 6.8 per cent more patients were discharged to their usual place of residence, and 
2 per cent more patients were readmitted within 30-days of discharge.   
Based on the coefficients of dummy 𝑁𝑗 and 𝐻𝑗 we cannot generally identify 
underlying time-invariant differences in processes and outcomes between the treatment 
groups, HASUs and non-HASUs, and the control group, except that non-HASUs have 4.7 per 
cent higher aspiration pneumonia rates across all quarters. No other underlying differences 
between HASU, non-HASU, and the rest of England are found.  
 Following the assumption of heterogeneous policy effects, i.e. non-HASUs continued 
the provision of care for a small proportion of the stroke population, the DiD coefficient of 
interest, DiD (non-HASUs) is significantly smaller for both processes, aspiration pneumonia 
and discharge to usual place of residence, and significantly larger for both mortality rates and 
readmission rates, in the period post-reorganisation. Our findings indicate that 24-hour scan 
rates are lower by 14.7 per cent in non-HASUs compared to HASUs and trusts in the rest of 
England; however, our estimates highlight no policy effect for HASUs when compared to 
trends in non-HASUs in London and the rest of England. Thrombolysis treatment rates show 
an opposing effect for HASUs and non-HASUs, with a significant decrease of 3.9 per cent in 
non-HASUs and a significant increase of 4.3 per cent in HASUs. Further policy effects for 
patients admitted to non-HASUs are a 1.9 per cent rise in 7-day mortality rate, a rise in 30-
day mortality rate by 2.3 per cent, a 2.3 per cent decrease in aspiration pneumonia rates and 
7.6 per cent decrease in rates of discharge to usual place of residence. Except for one 
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indicator, there is no effect for HASUs, but importantly there are negative effects on 
outcomes and processes for non-HASUs. This finding suggests that the reorganisation of 
stroke care led to significant different policy effects for patients admitted to HASUs and 
London non-HASUs. The estimates of the regional dummies show significant variation for 7-
day mortality rates across English regions. 
Alternate specifications and sensitivity analyses 
Our results confirm reduction in length of stay previously stated by Morris et al. 
(2014)  (see Appendix C); however, we find no significant effect of centralisation on 30-day 
in-hospital mortality. This is likely to be caused by limitations of our data, namely the use of 
aggregate-level data, inclusion of all patients regardless of whether their place of residence is 
in rural or urban areas, and the use of 30-day in-hospital mortality, as compared to mortality 
that includes deaths outside the hospital.  
 Results from sensitivity analysis, comparing changes in London HASU and non-
HASU trusts to a control group that comprises of seven English metropolitan areas show no 
significant policy effects on 7-day or 30-day in-hospital mortality for HASUs and non-HASU 
trusts in London (Appendix D). Furthermore, the centralisation of stroke care led to a 10.10 
per cent increase in 24-hour scan rates in HASU trusts 
6. DISCUSSION AND POLICY IMPLICTIONS 
The intention of stroke care centralisation in London was to increase provision of stroke 
processes and improve outcomes, while containing costs (Healthcare for London, 2008). Our 
results show that this policy objective was partly achieved by increased rates of thrombolysis 
treatment for patients admitted to HASUs. However, we find that approximately 15 per cent 
of patients still receive acute stroke care in London non-HASU trusts and estimates of the 
difference- in-difference analysis suggests that those patients are less likely to receive stroke-
specific processes and are experiencing worse outcomes. This is the first study to evaluate the 
impact of stroke service centralisation in London, addressing heterogeneity in provider 
performance that was masked by previous studies.  
The objective of centralised stroke care in London was to provide acute stroke services 
for the first 72 hours to patients in eight dedicated London HASUs, leading to the expectation 
of a reduction in patients receiving treatment in London non-HASU trusts. Our findings could 
be explained by four factors. First, variation in coding practice and in particular the wrong 
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coding of acute and rehabilitation stroke patients within HES. In fact, recorded stroke patients 
in non-HASUs could be rehabilitation patients who naturally would not receive processes, 
and are also more likely to experience worse health outcomes as they tend to be sicker 
compared to patients that are discharged after their acute episode. Second, while non-HASUs 
have no financial incentive in treating stroke patients, our results may indicate selection bias 
at non-HASU level due to unobservable differences in patient complexity. For example, non-
HASUs in London could end up treating sicker patients with multiple life threatening 
conditions, which are not observable in our data, and may preclude transfer to a HASU. 
Further, stroke cases treated in non-HASUs could be diagnosed with delay, because 
sometimes strokes present in complex multi-morbid patients and symptoms are difficult to 
read. Depending on the length of the delay, patients may not be suitable for transfer into a 
HASU upon diagnosis. Despite adjusting for comorbidities by using the Charlson index, age 
and other indicators of patient complexity, HES does not allow adjusting for severity of 
stroke. This may have explained whether some patients were treated in non-HASU trusts 
because they were considered clinically unfit for transportation. Lastly, and keeping the 
above alternative explanations in mind, our results could indicate differences in quality of 
care received at London HASU and non-HASU trusts. Poorer quality of care, potentially 
resulting from factors such as lower availability of specialist stroke staff, led to patients 
treated in London non-HASU trusts being less likely to receive stroke specific processes, 24h 
brain scans (-14.78) and thrombolysis treatment (-3.90), and being more likely to die within 
7-days (1.94) and 30-days (2.35). 
Our study has limitations. The use of HES data relies largely on the consistency of good 
quality coding practice. A previous study has shown that up to 16 per cent of all stroke 
patients are missed when compared to independent hospital stroke registers (Barer and 
Cassidy, 2014). However, the same study also found that the Stroke Improvement National 
Audit Programme (SINAP) omitted 30 per cent of all stroke patients, highlighting that of the 
two widely used sources for stroke policy evaluations, HES may be the more appropriate data 
source. In a recent study by Li and Rothwell (2016), systematic variation in coding practice 
of stroke patients between the weekday and weekend was highlighted. Even through the 
study has limited generalizability to the whole population due to its use of data from nine 
general practices, it flags up potential issues surrounding the quality of administrative 
datasets and its biases that could affect our estimates in unknown magnitude and direction. 
However, our study uses a tighter definition of stroke and we restricted our analysis to 
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emergency admissions, which may help to reduce bias. In this study we were not able to 
adjust for the type of stroke, which could bias performance of thrombolysis treatment rates 
and be a predictor for stroke outcomes. However, previous studies reported high 
inconstancies in stroke coding across English hospitals (Britton et al., 2012), which could 
introduce an additional bias into the analysis provided the type of stroke is coded wrongly. 
Last, policy makers have linked payments to performance targets based on clinical processes, 
which led to substantial investments into improving coding practices at the hospital- level. 
This might partly explain the estimated increase in 24-hour brain scan rates and thrombolysis 
treatment rates across the whole of England.  
As shown by previous studies, the centralisation of stroke care in London led to a step 
change in quality improvement, with processes and outcomes across London as a whole 
being consistently favourable to rates observed in the rest of England. The provision of 
centralised stroke care in London is therefore leading in the country, and improvements in 
London may have translated into learning for other service centralisations. However, while 
the majority of stroke patients received care in the anticipated clinical pathway, our findings 
show that the London stroke model would benefit from further exploration into reasons for 
why approximately 15 per cent of stroke patients still received care within London non-
HASU trusts and causes of poorer processes and outcomes for those patients. For example, 
one opportunity could be the revision of the London hub-model performance through joint 
collaboration between the three London Sustainability and Transformation Plans, and to 
develop strategies on how to drive further improvements in London and derive learning that 
could benefit other areas. An in-depth revision of the long-term impact of the London stroke 
model would also be of particular importance to policy makers when deciding whether a rigid 
area-wide policy is the appropriate tool for triggering a continuous long-term improvement, 
or whether locally driven, bottom-up initiatives could offer more flexibility to providers and 
hence better value in the long-term. Future research could explore the effectiveness of small 
scale local policies, which will help to develop an understanding of initiatives that could run 
in parallel to current efforts and potentially trigger further improvements of stroke care on a 
national scale. 
In this study, we found evidence to suggest underlying heterogeneity in processes and 
outcomes between providers following the introduction of an area-level centralisation of 
acute stroke care services in London, but we are not able to fully determine the reasons 
underlying such variation. Although the provision of stroke care has improved significantly 
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across the whole of England, with services in London remaining one of the best in the 
country, a renewed policy engagement into the London stroke model could lead to further 
improvements in processes and outcomes, ultimately affecting peoples lives.  
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Table I: Definitions of selected process and outcome measures 
Stroke measure Definition Inclusion Criteria Exclusion Criteria
24 hour brain scan rate Proportion of patients receiving a CT or MRI brain scan within 24 hours of admission OCPS codes = U05.1, U05.2, U21.1 or U05.2 with Z01.9 Death on day of admission
Thrombolysis rate Proportion of patients receiving clot-busting drug treatment OPCS codes = X83.3 Patients excluded from license agreement (<18 and >80)
Aspiration pneumonia rate Proportion of patients contracting aspiration pneumonia ICD-10 codes = J69.0, J69.8 recorded as primary or secondary diagnosis Exclusion if episode is prior to stroke episode
7-day in-hospital mortality rate Proportion of patients dying within 7-days of admission HES discharge method = 4 if length of stay <= 7 days None
30-day in-hospital mortality rate Proportion of patients dying within 30-days of admission HES discharge method = 4 if length of stay <= 30 days None
Discharge rate to usual place of residence within 56 days Proportion of patients discharged to their usual place of residence within 56 days of index admission HES discharge destination = 19 if length of stay <= 56 days Spell ending in death
30-day emergency readmission rate Proportion of patients readmitted within 30-days following discharge from an index admission HES admission method = 21, 22, 23, 24, 25 or 28 a nd admission < disdate(index) + 30 days None
 Note: Definitions and inclusion/exclusion criteria are adopted from Palmer at al (2013). 
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Table II (A): Summary statistics for London and rest of England trusts 
                         
 All trusts in London  All trusts in rest of England 
 Before (N=404)  After (N=388)  Before (N=2125)  After (N=2230) 
 Mean Std. Dev.  Mean Std. Dev.  Mean Std. Dev.  Mean Std. Dev. 
Number of admissions 95.49 59.88 
 
111.70 120.17  129.54 73.11  133.85 85.46 
Female patients (%) 47.91 14.30 
 
47.95 14.89  51.78 15.94  51.62 15.08 
Age (average) 71.01 6.41 
 
71.81 6.03  75.03 4.88  75.49 5.02 
Charlson Index (average) 5.90 2.37 
 
7.97 2.41  5.32 2.35  7.14 2.72 
Length of stay (average) 14.11 11.82 
 
9.37 8.62  14.49 17.49  12.59 16.32 
Admission from home (%) 84.38 28.07 
 
80.85 28.31  91.31 21.18  87.38 25.94 
Admission from hospital (%) 14.75 27.54 
 
18.34 27.46  7.62 19.73  11.90 25.40 
Scan rate (%) 37.47 22.69 
 
51.56 22.95  30.16 20.48  51.89 25.08 
Thrombolysis treatment rate (%) 0.91 2.62 
 
4.23 6.44  0.64 1.72  4.72 6.11 
7-day death rate (%) 7.81 4.93 
 
7.17 10.19  10.44 10.35  8.20 9.09 
30-day death rate (%) 15.97 10.54 
 
13.64 12.01  20.49 14.91  15.77 12.54 
Discharge to usual place of residence rate (%) 55.79 14.95 
 
57.76 16.97  50.76 16.79  57.43 18.12 
30-day readmission rate (%) 9.59 9.51 
 
12.74 9.53  7.31 7.06  9.57 8.91 
Aspiration pneumonia rate (%) 6.66 8.11   5.75 5.94   5.14 7.23   5.84 8.07 
Note. Before: Quarters 1 to 16; After: Quarters 17 to 32. 
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Table II (B): Summary statistics for HASU trusts and non-HASU trusts 
                        
 All HASU trusts  All non-HASU trusts 
 Before (N=128)  After (N=114)  Before (N=276)  After (N=259) 
 Mean Std. Dev.  Mean Std. Dev.  Mean Std. Dev.  Mean Std. Dev. 
Number of admissions 150.65 58.89 
 
271.75 63.80  69.91 39.74  33.57 26.13 
Female patients (%) 47.09 6.03 
 
48.35 3.82  48.29 16.80  47.96 17.79 
Age (average) 70.00 4.36 
 
72.49 2.14  71.47 7.12  71.58 7.15 
Charlson Index (average) 5.58 1.45 
 
7.68 1.18  6.05 2.68  8.04 2.79 
Length of stay (average) 11.50 3.62 
 
5.63 2.61  15.32 13.93  11.09 9.58 
Admission from home (%) 88.03 18.63 
 
92.19 15.15  82.69 31.39  78.94 29.52 
Admission from hospital (%) 10.44 17.77 
 
7.47 14.53  16.75 30.87  20.25 28.88 
Scan rate (%) 44.34 15.23 
 
72.03 10.28  34.29 24.80  41.98 21.10 
Thrombolysis treatment rate (%) 1.86 3.95 
 
10.80 6.94  0.47 1.50  1.07 3.08 
7-day death rate (%) 8.06 2.69 
 
6.00 1.75  7.69 5.68  7.77 12.37 
30-day death rate (%) 14.94 4.52 
 
11.99 2.96  16.45 12.35  14.56 14.45 
Discharge to usual place of residence rate (%) 55.70 7.04 
 
62.39 5.87  55.83 17.46  56.03 19.42 
30-day readmission rate (%) 8.54 2.95 
 
11.29 2.38  10.08 11.30  13.42 11.47 
Aspiration pneumonia rate (%) 5.22 2.93   5.85 2.21   7.33 9.55   5.70 6.97 
Note. Before: Quarters 1 to 16; After: Quarters 17 to 32. 
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Table III: Panel data model using two treatment groups 
24 hour brain scan 
(fixed effect)
Thrombolysis treatment 
(fixed effect)
Death within 7 days 
(random effect)
Death within 30 days 
(random effect) 
Aspiration pneumonia 
(random effect) 
Discharge to usual 
place of residence 
(fixed effect)
30-day emergency 
readmission (fixed effect) 
Independent variables
London non-HASUs - - 4.88 -4.35 4.74** - -
London HASUs - - 4.23 -8.96 2.45 - -
T 22.91*** 4.26*** -1.53*** -3.72*** 0.82*** 6.84*** 2.08***
DiD (non-HASUs) -14.78*** -3.90*** 1.94** 2.35** -2.32*** -7.61*** 1.39*
DiD (HASUs) 3.52 4.32*** -0.75 0.08 -0.59 0.13 0.86
Merger dummy - - 0.40 -3.02 -0.01 - -
Average age 0.00 -0.01 0.23*** 0.51*** 0.03 -0.51*** -0.04*
Average Charlson Index 0.93*** 0.10*** -0.16*** -0.22*** 0.06 0.55*** -0.02
Gender 0.02 0.01*** 0.00 -0.03*** -0.02*** 0.03** -0.01*
Hospital transfers -0.05*** 0.00 -0.06*** -0.11*** -0.03*** -0.09*** 0.00
North East - - 6.01* -4.19 2.85 - -
North West - - 3.66 -4.73 1.68 - -
Yorkshire and Humber - - 4.91 -6.27 1.46 - -
East Midlands - - 8.22** -3.80 3.88 - -
West Midlands - - 4.99 -5.28 2.44 - -
East of England - - 7.99** -3.27 3.15 - -
South East Central - - 6.81* -0.62 4.64* - -
South Central - - 3.98 -6.71 2.37 - -
South West - - 8.99*** -2.49 1.83 - -
Constant 24.36*** 0.35 -11.25*** -8.08 2.16 85.48*** 12.27
N 5147 5147 5147 5147 5147 5147 5147
R-squared 0.20 0.21 0.04 0.08 0.02 0.12 0.03
Hausman test (Prob>chi2) 0.00 0.00 0.20 0.51 0.52 0.00 0.00
Note: 1*** indicates that the variable has robust impact on dependent variable at 1% significance level, ** for 5%, and * for 10%; 2 The Hausman test was used to determine the preferred model 
effect; 3Fixed effect models ommit time invariant variables. 
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Figure 1: Proportion of stroke admissions divided by London Hyper Acute Stroke Unit trusts and London non-Hyper Acute 
Stroke Unit trusts 
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Appendix A: Trends in stroke specific process and outcome measures weighted by the number of admission 
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Appendix B: Fixed effect model versus random effect models (Two treatment groups) 
24 hour brain scan 
(fixed effect)
24 hour brain scan 
(random effect)
Thrombolysis treatment 
(fixed effect)
Thrombolysis 
treatment (random 
effect)
Death within 7 days (fixed 
effect)
Death within 7 days 
(random effect)
Death within 30 days (fixed 
effect) 
Death within 30 
days (random 
effect) 
Aspiration 
pneumonia (fixed 
effect) 
Aspiration 
pneumonia 
(random effect) 
Discharge to usual 
place of residence 
(fixed effect)
Discharge to usual 
place of residence 
(random effect)
30-day emergency 
readmission (fixed 
effect) 
30-day emergency 
readmission 
(random effect) 
Independent variables
London non-HASUs - 11.77* - 2.33** - 4.88 - -4.35 - 4.74** - 22.09*** - 0.66
London HASUs - 25.92*** - 4.27*** - 4.23 - -8.96 - 2.45 - 24.41*** - -0.78
T 22.91*** 22.81*** 4.26*** 4.18*** -1.55*** -1.53*** -3.73*** -3.72*** 0.85*** 0.82*** 6.84*** 6.69*** 2.08*** 2.11***
DiD (non-HASUs) -14.78*** -14.64*** -3.90*** -3.78*** 1.95** 1.94** 2.27** 2.35** -2.34*** -2.32*** -7.61*** -7.50*** 1.39* 1.31*
DiD (HASUs) 3.52 3.77* 4.32*** 4.41*** -0.74 -0.75 0.04 0.08 -0.58 -0.59 0.13 0.08 0.86 0.89
Merger dummy - 14.55* - 2.49** - 0.40 - -3.02 - -0.01 - 9.30 - 0.78
Average age 0.00 -0.06 -0.01 -0.02 0.22*** 0.23*** 0.50*** 0.51*** 0.01 0.03 -0.51*** -0.52*** -0.04* -0.07***
Average charlson index 0.93*** 0.91*** 0.10*** 0.11*** -0.13** -0.16*** -0.18** -0.22*** 0.06 0.06 0.55*** 0.66*** -0.02 -0.03
Gender 0.02 0.02 0.01*** 0.01*** 0.00 0.00 -0.03*** -0.03*** -0.02*** -0.02*** 0.03** 0.03*** -0.01* -0.01
Hospital transfers -0.05*** -0.08*** 0.00 -0.01 -0.06*** -0.06*** -0.12*** -0.11*** -0.03*** -0.03*** -0.09*** -0.10*** 0.00 0.00
North East - 9.28 - 1.89** - 6.01* - -4.19 - 2.85 - 18.28*** - 0.80
North West - 10.31 - 3.48*** - 3.66 - -4.73 - 1.68 - 18.91*** - -2.62
Yorkshire and Humber - 5.58 - 1.82* - 4.91 - -6.27 - 1.46 - 20.52*** - -1.63
East Midlands - 12.03 - 2.63** - 8.22** - -3.80 - 3.88 - 11.12* - -2.10
West Midlands - 3.84 - 2.88*** - 4.99 - -5.28 - 2.44 - 17.41*** - -2.49
East of England - 11.40* - 3.41*** - 7.99** - -3.27 - 3.15 - 15.09*** - -0.31
South East Central - 14.58** - 3.07*** - 6.81* - -0.62 - 4.64* - 14.85** - -2.15
South Central - 10.31 - 3.06*** - 3.98 - -6.71 - 2.37 - 21.33*** - -1.94
South West - 3.58 - 3.42*** - 8.99*** - -2.49 - 1.83 - 17.05*** - -3.27
Constant 24.36*** 17.26** 0.35 -2.34* -5.38** -11.25*** -14.32*** -8.08 5.75*** 2.16 85.48*** 63.84*** 12.27 15.19***
N 5147 5147 5147 5147 5147 5147 5147 5147 5147 5147 5147 5147 5147 5147
R-squared 0.20 0.25 0.21 0.24 0.04 0.04 0.08 0.08 0.01 0.02 0.12 0.13 0.03 0.03
Note: 1*** indicates that the variable has robust impact on dependent variable at 1% significance level, ** for 5%, and * for 10%; 2Fixed effect models ommit time invariant variables. 
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Appendix C: Panel data model using fixed effects and replicating Morris et al. (2014) 
Death within 
7 days 
Death within 30 
days 
Length of hospital 
stay
Independent variables
X_t - - -
T -0.95*** -2.37*** -1.64***
DiD -1.08 -0.37 -2.16*
Average age 0.13*** 0.36*** -0.39***
Average charlson index -0.09 -0.20 -0.16
Gender -0.02 -0.03* 0.03*
Hospital transfers -0.05*** -0.08*** 0.21***
Constant 1.57 -5.46 40.75***
N 2372 2372 2372
R-squared 0.05 0.09 0.15  
Note: *** indicates that the variable has robust impact on dependent variable at 1% significance level, ** for 5%, and * for 
10%. 
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Appendix D: Panel data model comparing London HASUs and London non-HASUs to seven English metropolitan areas as control a 
group 
24 hour brain scan 
(fixed effect)
Thrombolysis treatment 
(fixed effect)
Death within 7 days 
(random effect)
Death within 30 days 
(random effect) 
Aspiration pneumonia 
(random effect) 
Discharge to usual 
place of residence 
(fixed effect)
30-day emergency 
readmission (fixed effect) 
Independent variables
London non-HASUs - - 2.06 2.89 2.63 - -
London HASUs - - 1.34 -0.36 0.31 - -
T 17.26*** 4.18*** -0.33 -1.91* 1.42** 5.20*** 1.67**
DiD (non-HASUs) -8.46*** -3.69*** 0.60 0.46 -2.84*** -5.30*** 0.84
DiD (HASUs) 10.10*** 4.44*** -1.73 -1.70 -1.33 2.73 0.43
Merger dummy - - -0.42 -1.79 -0.90 - -
Average age -0.05 0.01 0.09** 0.56*** 0.17*** -0.63*** -0.03
Average charlson index 0.54** 0.07 -0.11 -0.30** 0.00 0.27 0.35***
Gender -0.06* 0.00 -0.01 -0.06*** -0.10*** -0.08*** 0.00
Hospital transfers -0.01 0.00 -0.06*** -0.04** -0.02 -0.10*** 0.04***
Constant 37.99*** -0.38 1.78 -18.91*** -2.06 104.40*** 8.37**
N 1286 1286 1286 1286 1286 1286 1286
R-squared 0.14 0.39 0.02 0.07 0.06 0.06 0.02
Note: 1 *** indicates that the variable has robust impact on dependent variable at 1% significance level, ** for 5%, and * for 10%; 2 Controls are Trusts in Birmingham, Bristol, Leeds, 
Liverpool, Sheffield, Southampton and Newcastle. 
 
 
